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Abstract
Angiogenesis is a fundamental process during development and disease, and many details of the underlying molecular
and cellular mechanisms are incompletely understood. Mitogen-activated protein kinase (MAPK)-activated protein
kinase 2 (MK2), a major downstream target of p38 MAPK, has recently been identified as a regulator of Interleukin
1β dependent angiogenesis in vivo, and in vitro data suggest a role of MK2 for VEGF-dependent angiogenic processes
in endothelial cells. We thus hypothesized that MK2 plays a role during physiological vascular development in vivo.
Vascular development was investigated in the retina of MK2-deficient mice. Retinal angiogenesis such as sprouting,
branching and pruning was unchanged in MK2-/- mice compared to wildtype littermates. Early arterial development
was also comparable between genotypes. However, with further expansion of vascular smooth muscle cells (SMC)
during maturation of the arterial network at later time points, the number of arterial branch points was significantly
lower in MK2-/- mice, resulting in a reduced total arterial area in adult mice. Isolated aortic smooth muscle cells from
MK2-/- mice showed a more dedifferentiated phenotype in vitro and downregulation of central SMC marker genes,
consistent with the known impaired migration of MK2-/- SMC.
In conclusion, MK2 is not required for physiological retinal angiogenesis. However, its loss is associated with an altered
genetic profile of SMC and an impaired arterial network in adult mice, indicating a distinct and probably cell-specific
role of MK2 in arteries.
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Introduction
Vascular development in higher organisms consists of
two principal mechanisms: Angiogenesis, i.e. endothelial
sprouting, branching, and pruning, and subsequent re-
modelling of the endothelial network towards a complex
3-dimensional system of arteries, capillaries and veins
[1]. During sprouting angiogenesis specialized endothe-
lial ‘tip cells’ guide the outgrowing sprout, while adjacent
endothelial ‚stalk cells’ build the trunk [2, 3]. In addition
branching forms interconnections between stalks, result-
ing in a 3-dimensional endothelial network, which is fur-
ther integrated by pruning, i.e. the selective degradation
of previously formed endothelial interconnections [4].
With expansion of the endothelial network vascular
smooth muscle cells (SMC) cover preformed endothelial
tubes, as a core step of development of the arterial
system [5].
Key components of the molecular control of angiogen-
esis are vascular endothelial growth factor (VEGF) as
well as Notch ligands and their cognate receptors [1].
However, beyond VEGF other stimuli are potent in-
ducers of angiogenesis under special conditions, such as
Interleukin 1β (IL-1β) [6, 7]. p38 MAP-kinase (MAPK)
and its downstream effector MAPK-activated protein
kinase 2 (MK2) are central regulators of sprouting, mi-
gration, proliferation, and actin polymerization in several
cell types [8]. MK2 has recently been identified as an es-
sential downstream component of IL-1β induced angio-
genesis in vitro and in vivo [9]. While IL-1β is a central
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angiogenic factor during tumour-associated or inflam-
matory angiogenesis [6, 7], physiological angiogenesis is
mainly regulated by VEGF [1]. Importantly, MK2 is sup-
posed to be required for VEGF-dependent signalling in
vitro [10]. MK2-deficient mice are viable, fertile, do not
show gross developmental defects [11] and survive until
senescence (own unpublished observations). While
MK2-deficient mice do not show an overt phenotype
under baseline conditions, they do in different animal
models under stress conditions. Atherosclerosis and as-
sociated inflammatory cell infiltration are reduced in
MK2-deficient mice [12], and they develop much smaller
brain infarcts after arterial occlusion than wildtype mice
[13]. Of note, we have recently shown that global defi-
ciency of MK2 prevents adverse remodelling but in turn
promotes endothelial healing of the arterial wall after in-
jury at the same time [14]. We thus reasoned that MK2
might play a role during physiological angiogenesis.
Here we analysed retinal vascular development, which
is prototypically controlled by VEGF, in wildtype and
MK2-deficient mice [11]. We show that retinal angio-
genesis is unaffected in the absence of MK2 but arterial
network phenotype is impaired, which might be attrib-
uted to a cell-specific role of MK2 in vascular SMC.
Material and methods
Mice
We investigated vascular development in the retina of
newborn and adult mice. The study was conducted con-
forming to the German Law for the Protection of
Animals and the NIH Guide for the Care and Use of
Laboratory Animals. Ethical approval was obtained from
local authorities of lower saxony (No. 04-13/1194 and §4
2016/117). Male and female global MK2+/- mice [11] on
a C57Bl/6 J background were mated to generate litters
with wildtype (WT) and knockout (MK2 KO) offspring.
Mice were born at the expected Mendelian ratio, and
there were no differences in retina size in both genotypes
(Additional file 1: Figure S1), consistent with previous re-
ports which demonstrated, that there is no general devel-
opmental defect in the global absence of MK2 [11].
Retina angiogenesis model
Retina preparation and immunofluorescence of whole-
mounts were performed at indicated timepoints as pre-
viously described [15, 16]. In brief, retinas were
dissected from PFA fixed eyes, washed in PBS and incu-
bated with PBS/1 % BSA/0,5 % TritonX100 for 24 h.
After incubation with antibodies diluted in PBS/1 mM
CaCl2/1 mM MgCl2/0.1 mM MnCl2/1%TritonX100 ret-
inas were sequentially rinsed in PBS/0.5 % BSA/0,25 %
TritonX100 and PBS and mounted on glass slides with
coverslips using mounting medium (DAKO). In the case
of Collagen-IV staining the primary as well as the
secondary antibody were diluted in PBS/1 % BSA/0,5 %
TritonX100/2 % donkey serum. The following antibodies
or reagents were used: Isolectin-B4-FITC (Vector, 1:100),
anti-smooth muscle actin-Cy3 (SMA, Sigma, 1:200),
anti-SMMHC (MC-352, Kamiya Biomedical Company),
anti-Caldesmon (D5C8D, Cell Signalling), anti-Collagen-IV
(Chemicon, 1:250), and appropriate Cy3- or FITC-
conjugated secondary antibodies (Dianova). Stained retinas
were analysed on a confocal laser scanning microscope
(Leica Inverted-2, Leica Microsystems, Heidelberg) or a
fluorescence microscope (Zeiss Axiovert). Quantitative ana-
lyses were done with Axiovision (Zeiss, Goettingen) and
ImageJ software (NIH, Bethesda) as previously described
[15, 16]. Arteries were identified in the murine retina based
on vascular morphology and SMA expression of the
vascular wall. Arteries identified by morphology also
expressed the SMC marker gene caldesmon (Additional
file 2: Figure S2). All vessels expressing SMMHC also
co-expressed SMA, but not all SMA-expressing vessels co-
expressed SMMHC during arterial expansion (Additional
file 2: Figure S2), suggesting that SMA was still the more
sensitive marker to identify SMC in the developing retina.
For quantification of SMA+ area (Fig. 2c) wholemount
fluorescence pictures of SMA-stained retinas were taken at
the same fluorescence intensity on a Zeiss Axiovert micro-
scope. Colors were then converted to black (SMA) and
white (background), black pixels counted with ImageJ, and
results given relative to the retinal area.
Aortic SMC isolation
Vascular SMC were isolated from 12-week-old mice by
enzymatic dispersion as described previously [14]. In
brief, mice were anesthetized by intraperitoneal injection
of esketamine and xylazine. Aortas were dissected,
rinsed with PBS and adventitial fat was removed. Aortas
were digested using a mixture of Collagenase II (CLS II,
No. C2-33, Biochrom) and Elastase (No. E1250, Sigma).
After washing cells were grown in dishes using DMEM
(Biochrom) supplemented with 20 % fetal calf serum
(PAA Laboratories) and penicillin/streptomycin.
Immunofluorescence
Murine aortic SMC were seeded to a calculated density of
30.000 cells per 0.7 cm2 on chamber slides (LabTek) and
grown in DMEM/20 % FCS. After gentle washing with
PBS cells were fixed with Cytofix fixation buffer (BD),
washed and incubated with antibodies against SMA (Cy3-
conjugated, C6198, Sigma-Aldrich) and SMMHC (MC-
352, Kamiya Biomedical Company), followed by washing
and anti-rat Alexa 488-conjugated secondary antibody
(LifeTechnologies). Nuclear staining and mounting was
done with Immunoselect Antifading Mounting Medium
DAPI (Dianova). Slides were analyzed on an Eclipse
TE2000-S microscope (Nikon) equipped with appropriate
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filter blocks and image processing software (NIS Elements
AR 4.20.01, Nikon).
Quantitative real-time PCR
Total RNA isolation was performed using commercial kits
(NucleoSpin RNA/Protein, Macherey-Nagel), and cDNA
was synthesized using a commercial kit (High Capacity
RNA-to-cDNA-Kit, Applied Biosystems). Real-time PCR
was performed on a CFX96 Touch™ Real-Time PCR
System (Bio-Rad Laboratories) using iQ™ SYBR® Green
Supermix (Bio-Rad Laboratories). Primers were as fol-
lows: SMA forward 5′-GTC CCA GAC ATC AGG
GAG TAA-3′, reverse 5′-TCG GAT ACT TCA GCG
TCA GGA-3′; SMMHC forward 5′-AGA GCA AAC
TCA GGA GAG GAA ACG A-3′, reverse 5′-TGA
GTC CCG AGC GTC CAT TTC T-3′; mouse smoothelin
forward 5′-GCG GCT CCT CCC GTC GGT CTG-3′,
reverse 5′-TGC CCC AGG GTA TTT TGC TCT CAG
T-3′; GAPDH forward 5′-TGC ACC ACC AAC TGC
TTA GC-3′, reverse 5′-GGC ATG GAC TGT GGT CAT
GAG-3′; β-actin (ACTB) forward 5′-CTT TGC AGC
TCC TTC GTT G-3′, reverse 5′-CGA TGG AGG GGA
ATA CAG C-3′; β-2 microglobulin (B2M) forward 5′-
ATG GCT CGC TCG GTG ACC CT-3′, reverse 5′-TTC
TCC GGT GGG TGG CGT GA-3′; and TATA-box bind-
ing protein (TBP) forward 5′-GAG CCA GGA CAA CTG
CGT T-3′, reverse 5′-ACA GCT CCC CAC CAT GTT
CTG GA-3′. All primers were designed by means of NCBI
Primer-BLAST. [17] Oligos were analyzed for self- and
hetero-dimers using OligoAnalyzer 3.1 [18]. Primers and
expected PCR products were tested for hairpins [19] and
finally purchased from Eurofins MWG Operon LLC.
GAPDH, ACTB, B2M, and TBP were selected as potential
reference genes using Genevestigator RefGenes (Nebion)
[20]. Expression stability was measured for all selected ref-
erence genes by use of the geNorm algorithm [21]. For
quantification of gene expression changes, the 2-ΔΔCt
method was used [22] to calculate relative fold changes
normalized to the geometric mean of the three reference
genes with the highest expression stability. All analyses
were performed in triplicates, and either the DNA tem-
plate or the reverse transcriptase was omitted for control
reactions.
Western blotting
Protein extraction was performed using commercial kits
(NucleoSpin RNA/Protein, Macherey-Nagel). Western
blotting was performed as previously described [23]. In
brief, the cleared supernatant from lysates was run on
commercial precast 4–12 % Bis-Tris gels (NuPAGE®,
LifeTechnologies) and blotted onto nitrocellulose mem-
branes (Trans-Blot®, Bio-Rad). After blocking with
Amersham ECL Prime Blocking Agent (GE) blots were
incubated with the primary antibody overnight at 4 °C.
Primary antibodies were used against SMA (ab5694,
Abcam), SMMHC (MC-352, Kamiya Biomedical Com-
pany), smoothelin (sc-28562, Santa Cruz), caldesmon
(sc-15374, Santa Cruz), calponin (sc-28546, Santa Cruz),
and GAPDH (5174, Cell Signaling). Proteins were de-
tected by enhanced chemiluminescence (Pierce ECL
Plus, Thermo Scientific) after labeling with a horseradish
peroxidase-conjugated secondary antibody (sc-2056 or
sc-2004, Santa Cruz). Densitometry was performed with
ImageJ.
Graphs were plotted with Prism 6 (GraphPad). Differ-
ences between groups were evaluated with student’s t-test.
P values below 0.05 were considered statistically significant.
Quantitative data is provided in Additional file 3: Table S1.
Results
Angiogenesis was investigated in the murine retina, in
which a vascular plexus develops de novo after birth [2].
In WT mice the retina was progressively grown by a
primitive endothelial network, covering the inner retinal
surface in a centrifugal fashion (Fig. 1a). This process
was unchanged in MK2 KO mice as assessed by measur-
ing the area covered by the endothelial cell (EC) network
over time, indicating that there is no gross sprouting
angiogenesis defect in MK2 KO mice. Consistently, the
number of sprouts at the growing angiogenic front was
comparable between genotypes at postnatal day (P) 5
(Fig. 1b). In addition, the number of branch points at P5
was unchanged (Fig. 1c), as was the number of vertical
branches at P10 (Fig. 1d), demonstrating that primary
development of the 3-dimensional EC network was
mainly unaffected by the global absence of MK2. We
next investigated pruning, which comprises retraction of
EC interconnections as a central remodelling process
during maturation of endothelial networks. As assessed
by counting sleeves with Collagen-IV positive basal
membranes lacking Isolectin-B4-positive EC, pruning was
unchanged at P7 in both genotypes (Fig. 1e). In summary,
these data indicate that MK2 is neither required for devel-
opment nor for remodelling of the endothelial plexus.
After initial development a part of the EC network in
the retina matures to give rise to the arterial system,
whereas another part is remodelled towards a venous
network, with capillaries remaining in between [24].
Regarding the previously described role of MK2 for
SMC migration [25] we next investigated arterial devel-
opment in the retina. The number of central arteries at
P12 was comparable between WT and MK2 KO mice,
as was the mean diameter of central arteries over time
(Fig. 2a), indicating that the initial setup of central ar-
teries was unaffected. In contrast, while the number of
arterial (SMA+) branch points was comparable at early
stages, from P20 on their number was progressively lower
in MK2 KO mice resulting in a significant difference
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between genotypes in adulthood (Fig. 2b, P < 0.001).
This reduction was apparent throughout the hierarchy
of junctions, but was even more prominent in higher
orders (Fig. 2b, P < 0.001). This indicated that impair-
ment of “arterialization” in MK2 KO mice was more
pronounced in the periphery of the arterial system,
which was also overt in wholemount SMA+-stained ret-
inas (Fig. 2c). As a result the total arterial area, i.e. the
SMA+ area relative to the total retinal area, was signifi-
cantly smaller in MK2 KO mice (Fig. 2c, P < 0.001). In
Fig. 1 Normal Angiogenesis in MK2-deficient mice. a The growing endothelial plexus. Isolectin-B4(IB4)-staining, quantification of the vascularized area (red
line) relative to whole retina area (white line). Scale bar: 1 mm. b Angiogenic sprouts (red dots). IB4-staining, quantification per high power field (HPF). Scale
bar: 200 μm. c Endothelial junctions. IB4-staining. Points were assigned according to the complexity of junctions (trifurcation 1 point, quattrofurcation 2
points, pentafurcation 3 points). Scale bar: 200 μm. d Vertical branching. IB4-staining. Analysis was done with a confocal microscope in order to count
vessels penetrating the middle layer of the retina (left). Scale bar: 200 μm. e Pruning. IB4-negative and Collagen-IV-positive sleeves were counted in HPF.
Scale bar: 100 μm. P indicates postnatal day. * = p< 0.05, ** = p< 0.01
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Fig. 2 (See legend on next page.)
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summary, these data indicate that MK2 is required for
normal development of the arterial system.
The phenotype observed in the retina suggested that
MK2 plays a role in SMC, however compared to other
tissues cells are difficult to isolate from murine retinas.
We therefore isolated vascular SMC from aortas of adult
WT and MK2 KO mice. Culture of aortic SMC demon-
strated that MK2 KO SMC appear more dedifferentiated
with a flattened morphology (Fig. 2d). Expression profil-
ing by RT-PCR and western blotting revealed pro-
nounced differences in the expression of prototypical
SMC marker genes such as SMA, SMMHC, smoothelin,
caldesmon and calponin (Fig. 2e, f and Additional file 4:
Figure S3). A close-up analysis of growing retinal arteries
revealed no gross differences between genotypes
(Additional file 5: Figure S4) in terms of attachment of
SMC or the distance between EC and SMC layers.
Together with the previously published observation that
SMC from MK2 KO mice show impaired migration in
vitro [14, 25], our data indicate that MK2 plays an
important probably cell-specific role for function or
maintenance of SMC.
Discussion
Several principle molecular and cellular components of
angiogenesis have been discovered [1], but many aspects
are still poorly understood. MK2 has recently been
identified as a critical downstream molecule of IL-1β in-
duced angiogenesis [9] as well as a regulator of VEGF-
dependent proangiogenic processes in endothelial cells
[10]. Therefore we hypothesized that MK2 plays an im-
portant role in physiological VEGF-driven angiogenesis.
We assessed vascular development ex vivo in the murine
retina, which is a well-established way of investigating
VEGF-induced physiological angiogenesis [15, 26]. To
our surprise physiological retinal angiogenesis was un-
affected in MK2-deficient mice. While our previous data
support a role of MK2 for enhancing angiogenesis under
special conditions such as inflammation or tumour for-
mation [9], the present data demonstrate that MK2 is
not essential for normal angiogenesis at baseline. Our
findings thus stand in contrast to the early report of in
vitro data that MK2 is essential for VEGF-induced EC
migration downstream of VEGF receptor 2 [10]. This
discrepancy, however, might be explained by the fact
that retinal angiogenesis depends on a complex interplay
of VEGF receptors 1, 2 and 3 and not only on VEGF re-
ceptor 2 [27]. Consistently, we have previously shown
that endothelial regeneration is enhanced in the absence
of MK2 after carotid injury [14], further supporting that
MK2 is not essentially required for endothelial growth in
VEGF-dominated environments.
MK2 regulates actin-remodeling and stress fiber for-
mation through phosphorylation of small heat shock
proteins in different cell types [8]. By this, MK2 also
plays an important role in migration of SMC [14, 25].
Since SMC cover preformed endothelial tubes during
vascular development, we analyzed MK2-dependent de-
velopment of the arterial system in the murine retina.
Initial setup of central arteries was normal, but later on
arterial network appearance was MK2-dependent, as
reflected by a significantly lower number of arterial
branch points and total arterial area in adult MK2-
deficient mice. Isolated SMC from MK2-deficient mice
showed a more dedifferentiated morphology paralleled
by an altered expression profile of prototypical SMC
marker genes, which corroborates and expands the find-
ing that SMA expression depends on MK2 [28, 29]. The
genes we found to be reduced in MK2-KO SMC are in
part important for migration and contraction of SMC,
and we and others have previously shown that migration
of MK-deficient SMC is impaired [14, 25]. While our
findings demonstrate that early arterial development
does not require MK2, we found a strong arterial pheno-
type at later time points, associated with an altered gene
profile of isolated SMC. This may either be explained by
impaired migration of SMC towards the periphery of the
arterial system at later stages of arterial development, or
a function of MK2 for maintenance of SMC. Albeit this
does not exclude a role of other cells to be involved in
the observed phenotype, our results support a cell-
specific role of MK2 during vascular development.
Conclusion
In conclusion, MK2 is not required for retinal angiogen-
esis under baseline conditions in vivo, which is a proto-
type of physiological VEGF-driven angiogenesis. MK2,
however, is required for marker gene expression and mi-
gration of SMC and important for normal arterial net-
work formation. In this our study adds to our very
recent finding that MK2 is essential for adaptive arterio-
genesis [30]. Although many genes have been associated
(See figure on previous page.)
Fig. 2 Impaired Arterial Network in MK2-deficient mice. a Normal number of central arteries in MK2-WT and -KO mice. SMA-staining. Scale bar: 400 μm.
b Arterial branchpoints. KO have less branchpoints especially in higher orders of junctions. SMA-staining. Scale bar: 200 μm. c Reduced total arterial area
in MK2-KO mice. Images were converted from SMA-stained retinas to generate a black-and-white-image. d Isolated SMC from WT and MK2-KO mice,
immunofluorescence. Pronounced flattening of SMC in KO mice as a surrogate of dedifferentiation. Scale bar: 50 μm. e RT-PCR of SMC marker genes.
f Western blotting for the same targets as in (e). Both e and f demonstrate reduced expression of prototypical SMC marker genes in MK2-KO mice. P
indicates postnatal day, w indicates weeks. * = p < 0.05, ** = p < 0.01
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with arterial identity [31] with most of these also being
important for angiogenesis (such as the Notch family),
to our knowledge our data for the first time identify a
regulator which specifically influences the arterial net-
work in the presence of normal angiogenesis. Our data
set the stage for future studies on the cell-specific role of
MK2 during development and maintenance of arteries.
Additional files
Additional file 1: Figure S1. Development of mice. A: Normal
distribution of genotypes in offspring of MK2+/- mice. B: Comparable
retina size in MK2 WT and KO-mice. (JPG 1587 kb)
Additional file 2: Figure S2. Identification of arteries in the retina. A:
Co-Staining for SMA (green) and SMMHC (red) demonstrates that SMA
labels much more SMC than SMMHC. B: Staining for the SMC marker
Caldesmon (red) and EC (Isolectin B4, green). Arteries and veins are readily
distinguishable by the typical morphology in the retina, which was verified
by SMMHC and caldesmon expression. Scale bar: 200 μm. (JPG 2011 kb)
Additional file 3: Table S1. Quantitative data analysed in the study.
Measurements referring to Figs. 1 and 2. (PDF 45 kb)
Additional file 4: Figure S3. Densitometry of western blots,
corresponding to Fig. 2f. (JPG 2344 kb)
Additional file 5: Figure S4. Growing artery in the retina. Staining for
EC (Isolectin B4, green) and SMC (SMA, red) demonstrates close proximity
of EC and SMC in the arterial wall independent of the genotype. Scale
bar: 20 μm. (JPG 2939 kb)
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